Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-03

Clinical Trial Update: Toujeo Versus NPH Self-titration Study [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Toujeo to NPH in self-titration for type 2 diabetes completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NPH (insulin NPH)
  • TOUJEO (insulin glargine)

Snippet

Sponsor: Elaine Chow | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED